Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for Prevention of Depression in Head and Neck Cancer
NCT00536172Phase 4Completed
- Sponsor
- University of Nebraska
- Start
- Dec 2007
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by University of Nebraska. Started Dec 2007; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00536172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00536172.